Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rapid Responses to:
|
|
Rapid Responses published:
|
|
|||
|
Joel Brind, professor Baruch College, City University of New York, New York, NY 10010
Send response to journal:
|
There is a technical error in the wording of my letter "Study shows greater cancer risk", which critiqued the study by Hannaford et al. last September. Specifically, In the penultimate paragraph, the following wording appears: "...a use pattern producing threefold increases in the risk of breast cancer." My original wording was: "...a use pattern producing threefold higher breast cancer increases." These do not mean the same thing. Specifically, I was referring (with reference to the study by Kahlenborn, et al.; #3 cited at the end of the sentence) to a 45% risk increase among women using OC before first full- term pregnancy (FFTP), compared to a 15% risk increase among women using OC only after FFTP. The former is properly described as threefold higher, since 45% is three times 15%. In contrast, by omitting the term "higher" in describing the risk increase, one ends up with "threefold increases in the risk of breast cancer", which clearly means a 200% increase in risk. Readers may justifiably accuse me of exaggeration if the error stands. Therefore a correction of the wording, to "...a use pattern producing threefold higher increases in the risk of breast cancer." would be in order. Competing interests: None declared |
|||